Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: I think RG anticipates a higher share price.

Aye. But at the levels we are dealing with (pre start ups like SSDI, Talis, and NuPower), I doubt if there will be any near term earnings potential. How do we value the acquired company vs shares given?

Share
New Message
Please login to post a reply